(Q61979951)
Statements
A Randomized Phase II Trial of Fludarabine/Melphalan 140 VS. Fludarabine/Melphalan 100 Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation for Patients With Multiple Myeloma (English)
0 references
January 2002
0 references
May 2013
0 references
52
0 references
18 year
0 references
70 year
0 references